We are live on ! Find out more
BSTG

Biostage, Inc. Common Stock
BSTG

Delisted

BSTG was delisted on the 5th of October, 2017.

Back to rankings

Fund managers haven’t disclosed any holdings of BSTG yet.

BSTG Hedge Fund Activity: Q4 2017 in Review

0 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Biostage, Inc. Common Stock (BSTG) for Q4 2017, worth a combined $0 — down 100% from $773K a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of BSTG and 0 opened new positions — a net loss of 25 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $285K sold.

  • 0 institutional investors held Biostage, Inc. Common Stock (BSTG) as of Q4 2017, down from 25 in Q3 2017.
  • Funds reported $0 of Biostage, Inc. Common Stock stock for Q4 2017, down 100% quarter-over-quarter.
  • 0 funds opened new Biostage, Inc. Common Stock positions in Q4 2017 and 25 closed out, a net change of -25 holders.
  • The largest Biostage, Inc. Common Stock seller in Q4 2017 was Vanguard Group, an estimated $285K sold.

Based on aggregated 13F filings for Q4 2017.